miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway

被引:31
|
作者
Bu, Wenjin [1 ,2 ]
Luo, Tianyou [3 ]
机构
[1] Chongqing Med Univ, Chongqing, Peoples R China
[2] Inner Mongolia Peoples Hosp, Dept Ultrason Med, Hohhot, Peoples R China
[3] Chongqing Med Univ, Dept Radiol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China
关键词
miR-1297; PTEN; Skp2; NSCLC; DOWN-REGULATION; PTEN; APOPTOSIS; GROWTH; SKP2; CHEMORESISTANCE; METASTASIS; EXPRESSION;
D O I
10.1089/dna.2017.3886
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a lipid and protein phosphatase and possesses an antitumor effect in lung cancers. miRNAs are reportedly abnormally expressed in human lung cancers. However, whether miRNA contributes to PTEN expression in non-small cell lung cancers (NSCLCs) has not been clearly clarified. In the present study, we found that miR-1297 probably binds with 3UTR sequence of PTEN and negatively regulated the levels of PTEN in NSCLC cells. First, the expression levels of PTEN and Skp2 were detected by western blotting in NSCLC specimens and paired normal tissue specimens. The results showed that decreased levels of PTEN were detected in NSCLC tissues, compared with paired control tissues (**p<0.01). The expression levels of PTEN were conversely correlated with the levels of Skp2 in clinical NSCLC specimens and NSCLC cell line. Transfection with miR-1297 mimic significantly promoted cell viability of A549 cells and NCI-H460 cells by downregulating the level of PTEN and upregulating the expression of Skp2. Interestingly, knockdown of Skp2 did not affect the expression of PTEN in A549 cells. Thus, miR-1297 might work as an oncogene by regulating PTEN/Akt/Skp2 signaling pathway in NSCLC cells. PTEN and Skp2 might be the potential targets in the clinical therapy of lung cancers.
引用
收藏
页码:976 / 982
页数:7
相关论文
共 50 条
  • [1] VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling
    Tan, Xiangbin
    Liao, Zefei
    Zou, Shuangyou
    Ma, Liangyun
    Wang, Aimin
    ONCOLOGY RESEARCH, 2020, 28 (01) : 3 - 11
  • [2] Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163
    Su, Lin
    Han, Dongrui
    Wu, Jingwen
    Huo, Xueyun
    TUMOR BIOLOGY, 2016, 37 (03) : 3925 - 3931
  • [3] Expression of SKP2 protein in non-small cell lung carcinoma
    Yang Chun-Lu
    Zhao Jun
    Zhao Su-Ying
    CHINESE JOURNAL OF CANCER RESEARCH, 2007, 19 (03) : 195 - 200
  • [4] miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer
    Liu, Chengyong
    Wang, Chunying
    Wang, Ji
    Huang, Haibin
    ONCOLOGY LETTERS, 2016, 12 (06) : 5177 - 5182
  • [5] Expression of SKP2 Protein in Non-small Cell Lung Carcinoma
    杨春鹿
    赵君
    赵苏英
    ChineseJournalofCancerResearch, 2007, (03) : 195 - 200
  • [6] The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer
    Takanami, I
    ONCOLOGY REPORTS, 2005, 13 (04) : 727 - 731
  • [7] Centromere protein U promotes cell proliferation, migration and invasion involving Wnt/β-catenin signaling pathway in non-small cell lung cancer
    Zhang, Q.
    Li, Y-D
    Zhang, S-X
    Shi, Y-Y
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) : 7768 - 7777
  • [8] MIR31HG promotes cell proliferation and invasion by activating the Wnt/-catenin signaling pathway in non-small cell lung cancer
    Zheng, Shuaiyu
    Zhang, Xiaojin
    Wang, Xian
    Li, Jiyuan
    ONCOLOGY LETTERS, 2019, 17 (01) : 221 - 229
  • [9] MiR-421 Is Overexpressed and Promotes Cell Proliferation in Non-Small Cell Lung Cancer
    Li, Xing
    Chen, Shao-Hua
    Zeng, Jin-Wu
    MEDICAL PRINCIPLES AND PRACTICE, 2020, 29 (01) : 80 - 89
  • [10] miR-150 promotes the proliferation and migration of non-small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway
    Jiang, Kanqiu
    Shen, Mingjing
    Chen, Yongbing
    Xu, Weihua
    ONCOLOGY REPORTS, 2018, 40 (02) : 943 - 951